HealthBaby Biotech (Hong Kong) Co., Ltd.
HealthBaby Biotech (Hong Kong) Co., Ltd
HealthBaby Group is the most established Asian cord blood bank with branches across Hong Kong, Macau, Thailand, Taiwan (HealthBanks) and USA (PacifiCord) with over 13 years experience. Apart from the global network, HealthBaby Group attained most international accreditations (include FACT, CAP, AABB, HOKLAS, ISO etc.). HealthBaby uses exclusive US patented technology for umbilical cord processing. HealthBaby processes whole umbilical cord tissue with unique processing developed by in-house R&D experts. HealthBaby is most recommended by Hong Kong O&G doctors and most entrusted by parents for 5 consecutive years, with 75% market share in Hong Kong.
HealthBaby - Kowloon (Kowloon), HealthBaby - Macau (), Thai HealthBaby (Bangkok)
HealthBaby Group was established and dedicated to cord blood industry since 2001. The Group adopts the most advanced storage and processing equipment, to ensure the life-long storage of customers' stem cells. HealthBaby Group has steadily developed its global network in Hong Kong, Macau, Taiwan, Thailand and the United States over 13 years. HealthBaby offers comprehensive umbilical cord blood and umbilical cord tissue storage service.
HealthBaby is most recommended by O&G doctors(1) and most entrusted by parents for 5 consecutive years, with 75% market share(2) in Hong Kong.
(1) IMS 2010 Cord Blood Bank Market Research in Hong Kong (with Private O&G physicians)
(2) Ipsos Healthcare 2009-2013 Cord Blood Bank Survey 3. According to official medical journal
The Group is the only Asian cord blood bank which is capable of setting up a branch in the United States and successfully passed FDA (Food and Drug Administration) rigorous and unexpected inspection in January 2010 and April 2011. HealthBaby Group has cryopreserved over 80,000 cord blood units.
HealthBaby works beyond the cord blood and umbilical cord stem cells storage services, we devote abundant resources in biotechnology research projects exploring stem cells medical applications for the betterment of human health.
HealthBaby Biotech (Hong Kong) Co., Ltd also works beyond the cord blood and umbilical cord stem cells storage services, we devote abundant resources in biotechnology research projects exploring stem cell medical applications for the betterment of human health.
HealthBaby provides specialized cord blood and cord collection kits with necessary collection tools (e.g. JMS blood bags, syringe and vacutainers etc) and detailed guidelines to OB/GYN doctors. The collection kits will be passed to enrolled clients in advance.
HealthBaby's container is thermal-insulated to provide stable storage conditions. A data logger is used to monitor the temperature throughout the transportation process to ensure the cord blood sample maintains a constant temperature.
HealthBaby provides in-house free-of-charge cord blood and cord samples collection service from designated hospitals (Hong Kong and Macau region) upon notification.
HealthBaby adopts a specialized, FDA-cleared stem cells processing system: AXP™ AutoXpress™ Platform. AXP™ consistently retrieves 98.7% MonoNuclear Cells (MNC) and 96.2% Total Nucleated Cells (TNC), based on audit by US Obstetrics & Gynaecology Society, which is about 18% higher than other systems. Samples are sterilized and processed individually to avoid mix-up.
HealthBaby is the ONLY private cord blood bank in Hong Kong that adopts the state-of-the-art and FDA-cleared automatic stem cells storage system: BioArchive® System. BioArchive® adopted closed system and automatic retrieval operation to eliminate the great temperature difference occurred in traditional storage tanks. Liquid nitrogen (-196℃) storage medium provides stable temperature and maintains the highest cell viability. BioArchive® is adopted by 116 cord blood banks in 36 countries worldwide, including Hong Kong public cord blood bank.
Licensing & Accreditation
Apart from basic AABB and ISO accreditation, HealthBaby is the FIRST and ONLY cord blood laboratory in Hong Kong accredited with The College of American Pathologists (CAP) and Hong Kong Laboratory Accreditation Scheme (HOKLAS), which prove the techniques, quality and storage service met up with the stringent standard of authoritative organizations.
HealthBaby Group has released over 750 cord blood units for HLA matching in 24 countries worldwide. Over 30 transplant cases including Unrelated/Direct Allogenic and Autologous, had been performed by over 20 medical institutions worldwide. In 2010, HealthBaby Group has achieved a successful autologous cord blood transplant for Neuroblastoma. HealthBaby has also released most cord blood units for autologous cord
blood transplants in Hong Kong: 2 pediatrics patients with Cerebral
Palsy and 1 with Neuroblastoma have successfully received their cord
blood, currently with satisfactory recovery.
HealthBaby offers full refund and compensation policies to protect clients's interests covering aspects of cord blood delivery, man-made negligence or accidents. HealthBaby is also the first cord blood bank committing a full refund and worldwide cord blood replacement or compensation up to US$50,000, as well as HK$20 million Professional Indemnity Insurance providing the greatest protection for clients. Besides, stem cells viability report is announced annually to ensure sample quality.
Please call HealthBaby hotline at 852 3188 8899 to know more about our service plan. Interest-free installment payment is available upon request.
HLA Typing Service is available as optional service